Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 167   

Articles published

GSK 1,560.64 +26.14 (1.70%)
price chart
5 Reasons Why Dividends Are Back: BHP Billiton plc, BP plc, GlaxoSmithKline ...
Dividends are back, with 2015 set to see the strongest underlying growth in three years at 6.4%, according to new research from Capita Asset Services.
Why Pensions Freedoms Day Will Be Good News For GlaxoSmithKline Plc, BP ...
Personally, I don't think that these fears will materialise -- indeed I think it will bode well for companies like GlaxoSmithkline Plc (LSE: GSK), National Grid Plc (LSE: NG.), BP Plc (LSE: BP.) and Hargreaves Lansdown Plc (LSE: HL.). Let me explain why.
Research Analysts' Weekly Ratings Changes for GlaxoSmithKline plc (GSK)
4/8/2015 - GlaxoSmithKline plc had its price target raised by analysts at Deutsche Bank from GBX 1,300 ($19.39) to GBX 1,600 ($23.86).
GlaxoSmithKline plc's Underperform Rating Reiterated at Credit Suisse ...  The Legacy
GlaxoSmithKline plc Receives Underperform Rating from BNP Paribas (GSK)  WKRB News
GlaxoSmithKline plc (ADR) Considers Changes To Its US Sales Staff ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been undergoing a seemingly rough patch in its US operations over the past year. In an attempt to remedy the situation, the company plans to make changes to its compensation program for its sales staff in the US ...
Glaxo Plans Changes to Compensation Program for U.S. Sales Team  Bloomberg
GlaxoSmithKline plc's "Underperform" Rating Reaffirmed at Credit Suisse Group ...
GlaxoSmithKline plc logo Credit Suisse Group AG restated their underperform rating on shares of GlaxoSmithKline plc (LON:GSK) in a research note issued to investors on Thursday.
GlaxoSmithKline plc Stock Rating Reaffirmed by Deutsche Bank (GSK)  Dakota Financial News
GlaxoSmithKline plc Earns "Underperform" Rating from Credit Suisse ...  WKRB News
On The Lookout For Delicious Dividends? Search No Further Than ...
Drugs leviathan GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has seen earnings whacked in recent times as the enduring issue of patent expirations across key products drags on, while recent misconduct in China has also smacked its performance in ...
GlaxoSmithKline plc Receives "A+" Credit Rating from Morningstar (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) has been given an �A+� credit rating by Morningstar. The investment research firm's �A+� rating indicates that the company is a low default risk.
GlaxoSmithKline plc (GSK) - Investment Analysts' Weekly Ratings Changes  WKRB News
Deutsche Bank Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)  Mideast Time
Is Fast-Growing Small-Cap Tasty Plc A Better Investment Than Stalwart ...
Tasty delivered investors nearly six times the return of GlaxoSmithKline over the last two years or so, and there's every reason to expect the restaurant chain to go on beating the pharmaceutical giant in the years to come.
Analyst Upgrades: Lululemon Athletica inc., GlaxoSmithKline plc., and Xerox ...
The shares of GSK are up 1.5% ahead of the bell, after Deutsche Bank raised its price target on the equity to 1,600P from 1,300P while keeping its "hold" rating.
Morning Worth Watching Stocks: Starbucks Corporation (SBUX ...
GlaxoSmithKline plc (GSK) of the Healthcare sector (Drug Manufacturers - Major) is up 2.34% already this morning, a change from open of 0.53%.